Skip To Content
BuzzFeed News Home Reporting To You

Utilizamos cookies, próprios e de terceiros, que o reconhecem e identificam como um usuário único, para garantir a melhor experiência de navegação, personalizar conteúdo e anúncios, e melhorar o desempenho do nosso site e serviços. Esses Cookies nos permitem coletar alguns dados pessoais sobre você, como sua ID exclusiva atribuída ao seu dispositivo, endereço de IP, tipo de dispositivo e navegador, conteúdos visualizados ou outras ações realizadas usando nossos serviços, país e idioma selecionados, entre outros. Para saber mais sobre nossa política de cookies, acesse link.

Caso não concorde com o uso cookies dessa forma, você deverá ajustar as configurações de seu navegador ou deixar de acessar o nosso site e serviços. Ao continuar com a navegação em nosso site, você aceita o uso de cookies.

Pfizer Said It's Postponing Drug Price Increases After Meeting With Trump

The announcement came one day after Trump slammed drugmakers on Twitter, saying they "should be ashamed" for raising prices "for no reason."

Last updated on July 11, 2018, at 2:08 p.m. ET

Posted on July 10, 2018, at 8:35 p.m. ET

Fred Tanneau / AFP / Getty Images

Pharmaceutical giant Pfizer said Tuesday that it is deferring recent drug price increases until the end of the year after an "extensive discussion" between the company's CEO, President Trump, and Health and Human Services Secretary Alex Azar.

The announcement came after Trump tweeted Tuesday that he had met with Pfizer CEO Ian Read to discuss his "drug pricing blueprint" — his plan to fulfill a campaign promise to lower drug prices across the board — and that the company would reverse the recent price hikes as a result.

Pfizer confirmed the meeting in a statement, adding that it plans to defer the price increases that went into effect on July 1 "to give the president an opportunity to work on his blueprint to strengthen the healthcare system and provide more access for patients."

Just talked with Pfizer CEO and @SecAzar on our drug pricing blueprint. Pfizer is rolling back price hikes, so American patients don’t pay more. We applaud Pfizer for this decision and hope other companies do the same. Great news for the American people!

Senator Ron Wyden responded to the meeting Wednesday with a stern letter to Azar and Read asking for details of the deal between Pfizer and the administration by July 25th.

"Like many pronouncements coming out of the Administration, the President's agreement with Pfizer is long on theatrics and short on real and sustainable relief for patients being mugged at the pharmacy counter," Wyden wrote.

On Monday, Trump slammed Pfizer and other drugmakers on Twitter, saying they "should be ashamed" for raising prices "for no reason."

"They are merely taking advantage of the poor & others unable to defend themselves," he tweeted.

The bash was likely in response to a report in the Financial Times that Pfizer, one of the largest pharmaceutical companies in the US, had raised the price of 100 drugs, including Viagra, effective July 1. However, Pfizer disputed that number in an email to BuzzFeed News, saying it was actually "40 brands," but that the Financial Times "counted different dosages of the same product as different products."

A Wells Fargo report also found that Pfizer increased the prices of 41 drugs in July, according to the Washington Post.

Whatever the increase, Trump vowed to take action in his tweet on Monday, writing, "We will respond!"

Pfizer & others should be ashamed that they have raised drug prices for no reason. They are merely taking advantage of the poor & others unable to defend themselves, while at the same time giving bargain basement prices to other countries in Europe & elsewhere. We will respond!

The price hikes were also enacted months ago when Trump claimed that pharmaceutical companies big and small were planning to make "voluntary, massive drops in prices."

The Department of Health and Human Services did not immediately respond to a request for comment.

A BuzzFeed News investigation, in partnership with the International Consortium of Investigative Journalists, based on thousands of documents the government didn't want you to see.